COLL
COLLEGIUM PHARMACEUTICAL, INC
COLLEGIUM PHARMACEUTICAL, INC (COLL) has 15 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 10, 2026.
Insiders have net sold $3.4M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Vikram Karnani
- Employees:423
- HQ:Stoughton, MA, US
- IPO:2015-05-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.4M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$1.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 20 | $681 | May 20 | SEC ↗ | |
Freund John GordonFirst filing | Director | Sale | 4,127 | $143K | May 18 | SEC ↗ |
Lurker NancyFirst filing | Director | Sale | 4,500 | $162K | May 15 | SEC ↗ |
BOHLIN GAREN GFirst filing | Director | Sale | 8,700 | $323K | May 13 | SEC ↗ |
| EVP & General Counsel | Sale | 13,976 | $488K | Mar 20 | SEC ↗ | |
Dieter DavidFirst filing | EVP & General Counsel | Sale | 6,224 | $228K | Mar 11 | SEC ↗ |
Dreyer ScottFirst filing | EVP & Chief Commercial Officer | Sale | 49,976 | $2.0M | Mar 5 | SEC ↗ |
Related companies
COLLEGIUM PHARMACEUTICAL, INC is in the Healthcare sector.